EP 1361871 A2 20031119 - MEDICAMENT FORMULATION CONTAINING A MUSCARINIC AGONIST
Title (en)
MEDICAMENT FORMULATION CONTAINING A MUSCARINIC AGONIST
Title (de)
ARZNEIMITTELFORMULIERUNG DIE EINEN MUSKARINISCHEN AGONISTEN ENTHÄLT
Title (fr)
COMPOSITION MEDICAMENTEUSE QUI CONTIENT UN AGONISTE MUSCARINIQUE
Publication
Application
Priority
- DE 10106971 A 20010215
- EP 0201374 W 20020209
Abstract (en)
[origin: WO02064124A2] The invention relates to a novel medicament formulation containing the muscarinic agonist talsaclidine and to a method for the production thereof.
IPC 1-7
IPC 8 full level
C07D 453/02 (2006.01); A61K 9/28 (2006.01); A61K 9/32 (2006.01); A61K 9/36 (2006.01); A61K 31/439 (2006.01); A61K 47/26 (2006.01); A61P 25/28 (2006.01); A61K 9/20 (2006.01)
CPC (source: EP)
A61K 9/2866 (2013.01); A61K 31/439 (2013.01); A61P 25/28 (2017.12); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01)
Citation (search report)
See references of WO 02064124A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02064124 A2 20020822; WO 02064124 A3 20021205; AR 033862 A1 20040107; AU 2002247705 A1 20020828; CA 2434976 A1 20020822; DE 10106971 A1 20020829; EP 1361871 A2 20031119; JP 2004518710 A 20040624; MX PA03007272 A 20031204; UY 27170 A1 20020930
DOCDB simple family (application)
EP 0201374 W 20020209; AR P020100515 A 20020215; AU 2002247705 A 20020209; CA 2434976 A 20020209; DE 10106971 A 20010215; EP 02716755 A 20020209; JP 2002563919 A 20020209; MX PA03007272 A 20020209; UY 27170 A 20020213